Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bespak maintains improved performance:

This article was originally published in Clinica

Executive Summary

Strong demand for its asthma inhaler valves drove first-half sales and profit increases at Bespak, the UK-based drug delivery device manufacturer. Sales rose by 10.4% to £39.4 million ($67 million) in the six months to November 1st, 1996. Pre-tax profit for the half year was 42.9% ahead of year-earlier figures, at £5 million. Bespak, which returned to profitability in fiscal 1996, is forecasting continued progress through the second half-year. The company expects further growth in UK sales of drug delivery devices, and anticipates improved profitability for its US operations.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel